Transforming growth factor beta2 (TGFβ2) is a multifunctional protein which is expressed in several embryonic and adult organs. TGFB2 mutations can cause Loeys Dietz syndrome, and its dysregulation is involved in cardiovascular, skeletal, ocular and neuromuscular diseases, osteoarthritis, tissue fibrosis, and various forms of cancer. TGFβ2 is involved in cell growth, apoptosis, cell migration, cell differentiation, cell-matrix remodeling, epithelial-mesenchymal transition, and wound healing in a highly context-dependent and tissue-specific manner. Tgfb2 −/− mice die perinatally from congenital heart disease, precluding functional studies in adults. Here, we have generated mice harboring Tgfb2 βgeo (knockout-first lacZ-tagged insertion) gene-trap allele and Tgfb2 flox conditional allele. Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− mice died at perinatal stage from the same congenital heart defects as Tgfb2 −/− mice. β-galactosidase staining successfully detected Tgfb2 expression in the heterozygous Tgfb2 βgeo fetal tissue sections. Tgfb2 flox mice were produced by crossing the Tgfb2 +/βgeo mice with the FLPeR mice. Tgfb2 flox/− mice were viable. Tgfb2 conditional knockout (Tgfb2 cko/− ) fetuses were generated by crossing of Tgfb2 flox/− mice with Tgfb2 +/− ;EIIaCre mice. Systemic Tgfb2 cko/− embryos developed cardiac defects which resembled the Tgfb2 βgeo/βgeo , Tgfb2 βgeo/− , and Tgfb2 −/− fetuses. In conclusion, Tgfb2 βgeo and Tgfb2 flox mice are novel mouse strains which will be useful for investigating the tissue specific expression and function of TGFβ2 in embryonic development, adult organs, and disease pathogenesis and cancer.
profibrotic cytokines that regulate cell growth, apoptosis, cell migration, cell differentiation, cell-matrix remodeling, epithelial-mesenchymal transition, and wound healing in a highly context-dependent and tissue-specific manner (Sonnylal et al. 2007; Soderberg et al. 2009; Kulkarni et al. 2002) . Activated TGFβs interacts with TGFβ receptor type II and type I, which propagate the TGFβ signal into the cell by phosphorylating TGFβ receptor-specific canonical Smads (i.e., Smad2 and Smad3) and non-Smad mediators (e.g., TAK1, ERK MAPK) (Iwata et al. 2012; Yumoto et al. 2013; Akhurst and Hata 2012) . The dysregulation of the TGFβ pathway leads to a number of human diseases and disorders, including tissue fibrosis and cancer (Akhurst and Hata 2012) , underscoring the essential roles the TGFβ isoforms have in vivo.
TGFB2 mutations have been identified in Loeys-Dietz syndrome (LDS) (OMIM# 614816613795, 610380) (Lindsay et al. 2012; Boileau et al. 2012; Renard et al. 2012 ). LoeysDietz syndrome is a connective tissue disorder, predisposing individuals to serious cardiovascular, craniofacial, cutaneous, ocular, and skeletal complications (Loeys et al. 2013) . The cardiovascular complications of LDS patients include congenital heart defects, aortic aneurysm, cardiomyopathy, and heart valve complications (Maccarrick et al. 2014 ). TGFB2 signaling is associated with cardiovascular complications of Kawasaki disease (Shimizu et al. 2011) . TGFB2 levels are elevated in the myocardial tissue of the patients of dilated cardiomyopathy (Pauschinger et al. 1999) . Furthermore, TGFB2 is elevated in diseased mitral valves and aortas of Marfan syndrome patients, and mouse craniofacial defects, in which TGFβ signaling is also increased (Iwata, 2012 9286/id; Ng et al. 2004; Nataatmadja et al. 2006; Jain et al. 2009 ). Spatiotemporally restricted cardiac expression of Tgfb2 and its overlap with Tgfb1 or Tgfb3 in various cardiac cell lineages including endocardial, myocardial, cardiac neural crest, and vascular smooth muscle cells in embryonic hearts (Dickson et al. 1993; Azhar et al. 2003; Molin et al. 2003 ) suggest a critical cell type specific autocrine-paracrine and synergistic roles of TGFβ2 in regulation of TGFβ signaling during cardiovascular development and remodeling. Systemic knockout mice of Tgfb2 exhibit developmental defects in multiple organs and die at birth due to cardiac malformations, indicating that TGFβ2 is indispensable for embryonic tissue development (Sanford et al. 1997; Azhar et al. 2011; Bartram et al. 2001 ).
Here, we report on the generation and characterization of mice carrying a novel and flexible gene-trap knockout-first, lacZ tagged insertion allele of Tgfb2 (hereafter referred to as Tgfb2 βgeo ). Three independent lines of the correctly targeted Tgfb2 βgeo ES cell clones were obtained from the European Conditional Mouse Mutagenesis Program (EUCOMM) for generating Tgfb2 βgeo mice. These ES clones had passed all rigorous quality control tests of the EUCOMM (Skarnes et al. 2011) . Tgfb2 βgeo ES cell clones and Tgfb2 βgeo mice were validated by an extensive 5′ and 3′ screening (Fig. 1A-B) . In this targeting scheme, homologous recombination can result in a Tgfb2 βgeo allele where gene function would be ablated by a polyadenylation (polyA) signal-mediated transcriptional stop at the end of the lacZ expression marker gene that is driven off the Tgfb2 promoter. Tgfb2 +/βgeo mice were maintained on C57BL/6 genetic background. Genotyping analysis of the newborn offspring indicated that all Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− mice died at the perinatal stage (Fig. 1C, 2A -B). Timed-pregnant heterozygous Tgfb2 βgeo and Tgfb2 +/− (C57BL/6) females that crossed to heterozygous Tgfb2 βgeo males were used to produce embryos/fetuses for gross morphological and histological characterization. The data indicated that Tgfb2 βgeo/βgeo and Tgfb2 βgeo/− fetuses at E16.5-E18.5 appeared grossly abnormal and exhibited abnormal body vasculature ( Fig. 2A-B) . Next, Tgfb2 expression was measured in Tgfb2 βgeo/βgeo hearts by real-time quantitative PCR (qPCR) via an intron spanning (exon 6-7) Universal ProbeLibrary assay. The data indicated that the amount of wild-type Tgfb2 transcript containing the exon 6-7 was significantly downregulated in Tgfb2 βgeo/βgeo fetal hearts compared to the wild-type fetuses (Fig. 2C ). This suggests that although Tgfb2 expression is abated, the polyA signal-mediated transcriptional stop at the end of the lacZ gene-trap cassette is not able to completely abolish the wild-type Tgfb2 expression. Since we expected the Tgfb2 promoter to drive the lacZ expression marker gene, the expression of lacZ was also analyzed by both RT-PCR, and β-galactosidase (X-gal) staining of fetal tissue cryosections. Limited data indicated remarkable Tgfb2 expression associated with ossification within cartilage primordium of neural arch (Fig. 2E) , mid-shaft region of left humerus (Fig.  2F) , rib (Fig. 2G) , and distal part of shaft of right ulna (Fig. H) during late embryonic development. The data confirmed the presence of lacZ expression as an indicator of the endogenous Tgfb2 expression in Tgfb2 +/βgeo fetuses. Overall, as reported previously in Tgfb2 −/− fetuses (Sanford et al. 1997) , the significant loss of wild-type Tgfb2 mRNA expression is consistent with the observed perinatal lethality of Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− mice.
Histological examination of serial tissue sections indicated multiple cardiac structural defects in Tgfb2 βgeo/βgeo and Tgfb2 βgeo/− fetuses ( Fig. 3A-H) . Tgfb2 βgeo/βgeo as well as Tgfb2 βgeo/− fetuses developed similar cardiac malformations of both the outflow tract and inflow tract. The outflow tract malformations of the mutant fetuses included double-outlet right ventricle (DORV) (100% cases), persistent truncus arteriosus (PTA) (27.2% cases), and abnormal morphology and thickening of aortic and/or pulmonary valves (100% cases) (Fig. 3A-D) . In addition, the mutant fetuses developed double-inlet left ventricle (DILV) and/or overriding of tricuspid valves orifice via a perimembranous inlet ventricular septal defect (VSD) (100% cases), and abnormal morphology and thickening of tricuspid and mitral valves (100%) (Fig. 3E-H) . Malformations of myocardium, epicardium, and aortic arch arteries also found but were not carefully determined in Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− fetuses. Notably, the overall penetrance of the observed cardiac valve and septal defects was significantly higher in Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− fetuses compared to Tgfb2 −/− fetuses. We attribute this difference in the phenotypic penetrance between the Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− (C57BL/6) and Tgfb2 −/− (129/BL-Swiss) (Azhar et al. 2011; Bartram et al. 2001) mice to different genetic background of the two strains. Collectively, our results show that Tgfb2 βgeo/βgeo or Tgfb2 βgeo/− fetuses exhibit high penetrance of similar cardiac phenotypes that are reported previously in Tgfb2 −/− fetuses. Thus, Tgfb2 βgeo allele represents a novel knockout-first, lacZ-tagged insertion and conditional-ready allele for Tgfb2.
Mice with conditional (Tgfb2 flox ) allele were produced by crossing the conditional-ready Tgfb2 +/βgeo female mice with the Flp recombinase germline deleter (FLPeR) male mice (Farley et al. 2000) , which removed the entire FRT-flanked lacZ-neomycin (βgeo) gene-trap cassette (Fig. 1A , C-E). Genomic PCR analysis confirmed that Flp recombinase resulted in mice harboring Tgfb2 flox allele in which loxP sites flanked the exon 2 of Tgfb2 ( Fig. 1D-E) . Subsequently, Tgfb2 flox/− mice were produced by intercrossing the Tgfb2 +/flox and Tgfb2 +/− (C57BL/6) mice. Tgfb2 flox/− and Tgfb2 flox/flox mice were viable and fertile, and the adult Tgfb2 flox/− mice were normal and indistinguishable from the wild-type littermate mice (Fig.  1D) . In a proof of principle experiment, embryos with a Tgfb2 conditional knockout (Tgfb2 cko/− ) allele were generated by crossing the Tgfb2 flox/− mice with Tgfb2 +/− ;EIIaCre transgenic mice. EIIaCre mice have ubiquitous Cre activity and are known to generate germline or systemic knockout animals from the floxed animals (Holzenberger et al. 2000; Doetschman et al. 2012b) . The data indicated that EIIaCre recombinase successfully excised the exon 2 of Tgfb2 in vivo (Fig. 4A ). Histological and immunohistochemical analyses were done and the changes in cardiac structure and morphology were cataloged from the wild-type control, Tgfb2 flox/− ;EIIaCre − , and Tgfb2 flox/− ;EIIaCre + (i.e., Tgfb2 cko/− ) fetuses at E16.5-E18.5. Cross comparison of cardiac phenotype indicated that Tgfb2 cko/− fetuses developed a spectrum of heart defects which resembled the Tgfb2 βgeo/βgeo , Tgfb2 βgeo/− , and Tgfb2 −/− fetuses ( Fig. 4B-G ). These data indicate that Tgfb2 flox mice are fully capable of producing robust conditional Cre-mediated deletion of Tgfb2 in vivo.
Systemic Tgfb2 deletion studies by very nature are limited in scope, and leave a fundamental gap in our understanding of the critical cell-source of TGFβ2 (endocardium, neural crest and/or myocardium, second heart field, epicardium) as well as its regulatory mechanisms (canonical and/or non-canonical) that mediate cardiovascular development and remodeling. TGFβ2 is involved in adult cardiovascular pathologies including aortic aneurysm, cardiac fibrosis and cardiomyopathy, mitral valve prolapse, and calcific aortic valve disease. In addition, TGFβ2 plays important role in muscular, craniofacial, ocular, chronic liver, kidney, neurodegenerative and autoimmune diseases, osteoarthritis, tissue fibrosis, and various forms of cancer. The expression of Tgfb2 in adult wild-type mouse cardiovascular tissues has not been determined yet. It is known that Tgfb2 expression increases in diseased tissues, and many other pathophysiological states and cancer (Iwata et al. 2012; Lindsay et al. 2012; Friess et al. 1993) . Collectively, Tgfb2 +/βgeo mice with lacZ-tagged insertion allele will be useful for localizing endogenous Tgfb2 expression in embryos and adults, changes in Tgfb2 expression and distribution in a longitudinal study in the pathogenesis of cardiovascular and other diseases, and in response to stress (i.e., Ang II, aortic coarctation, high fat diet) to induce cardiovascular disease states (e.g., aortic aneurysm, cardiac hypertrophy, atherosclerosis). Finally, Tgfb2 flox mice open a new frontier, and have unlimited potential to advance the understanding of TGFβ2 function in embryonic development, tissue homeostasis in adults, pathogenesis of cardiovascular and other diseases, and various forms of cancer. In conclusion, the generation and characterization of Tgfb2 βgeo and Tgfb2 flox mice is a major first step towards defining the tissue-specific expression and function of Tgfb2 and TGFβ2 regulatory mechanisms in organ development, function, and disease.
Methods

Generation of Tgfb2 βgeo and Tgfb2 flox mice
All animal breeding and procedures are approved by the Institutional Animal Care and Use Committee (Indiana University School of Medicine). Tgfb2 βgeo mice will be made available to other investigators consistent with the general guidelines, policies, and procedures of the Indiana University. Mouse ES cells with Tgfb2 knockout-first lacZ tagged insertion allele (ID:47128, Targeting Confirmed) are available to all non-profit non-commercial investigators through EUCOMM. Three independently targeted clones of Tgfb2 βgeo ES cells were obtained from the EUCOMM. The ES cells were male and heterozygous for the Tgfb2 βgeo allele. The specific details and the complete DNA sequence of the Tgfb2 βgeo gene targeting construct (L1L2_Bact_P) are available in the GeneBank (Accession# JN955293). Tgfb2 is located on mouse chromosome 1 and has 7 exons (NCBI Gene ID# 21808). Tgfb2 βgeo is a targeted trap allele which functions as a gene-trap knockout (Skarnes et al. 2011 ). The targeting vector contained an IRES-LacZ trapping cassette and a floxed promoter-neomycin cassette inserted into an intron 1 of the Tgfb2. The mutagenic cassette had an Engrailed (En2) splice acceptor sequence and poly-A transcription termination signals which was expected to disrupt the Tgfb2 function while expressing the lacZ gene under the control of the endogenous Tgfb2 promoter for studying its gene expression. Mycoplasma testing and chromosome counting was done by EUCOMM. All Tgfb2 βgeo ES cell clones were mycoplasma negative. Also, chromosome counting had found no chromosomal abnormalities in Tgfb2 βgeo ES cell clones.
We validated the Tgfb2 βgeo ES cell clones by 3′ screen and 5′ screen for correct gene targeting using long range PCR (LR-PCR) method. These LR-PCR reactions amplified very large and specific PCR products, ranging from 3.9 kb to 7.4 kb in the Tgfb2 βgeo targeted clones. The 5′ LR-PCR had confirmed correct integration of the Tgfb2 on the 5′ side by Tgfb2-specific 5′-outside forward primer (F74 or F75) and constant cassette specific 3′-reverse primer (R66 or R75). The subsequent 5′ LR-PCR product was sequenced with a primer to the upstream FRT to verify the Tgfb2 and FRT site. In addition, the 3′ LR-PCR had confirmed the correct integration of the Tgfb2 on the 3′ side by Tgfb2-specific 3′-outside reverse primer (R76 or R77) and constant cassette specific 5′-forward primer (F103, F76) . The subsequent LR-PCR product was sequenced with a primer to the downstream loxP (Tgfb2-rev primer, R64) to verify the Tgfb2 and loxP site. Two or more sets of LR-PCR assays were used in both 5′ and 3′ screen with similar results. The following primers were used in the LR-PCR 5′ screen: CTCCTGATCTCCAGTGATCTTGTGTAAC (F74, forward 5′-outside primer), GTGATATGTGCAATGTCTGATGTACTC (F75, forward 5′-outside primer), CACAACGGGTTCTTCTGTTAGTCC (R66, reverse universal/cassette primer). The following primers were used in the LR-PCR 3′ screen: GCAATAGCATCACAAATTTCACAAATAAAGCA (F103, forward universal/cassette primer), GAGATGGCGCAACGCAATTAATG (F76, forward universal/cassette primer), CAACACACATGGTTCCAACACCACCGCCG (R76, reverse 3′-outside primer), CTCACTATCCTTAGAGAGCTAAGCAAGC (R77, reverse 3′-outside primer). The following PCR conditions were used: denaturation: 93°C/3 min; annealing and amplification: 92°C/15 sec, 65°C/30 sec, 65°C/8 min (−1°C/cycle) for 8x; 92°C/15 sec, 55°C/30 sec, 65°C/8 min (+20 sec/cycle) for 30x; 65°C/9 min, 4°C hold. Phusion® HighFidelity PCR Master Mix with HF Buffer (New England Biolabs, Inc) was used for amplifying the large PCR products in the both LR-PCR screens.
Strain of origin of Tgfb2 βgeo ES cell clones was C57BL/6N (Parental ES cell line: JM8) and the ES cells carried the genotype A/a (Agouti heterozygous). The dominant agouti coat color gene is restored in JM8 cells by targeted repair of the C57BL/6 nonagouti mutation (Pettitt et al. 2009 ). Tgfb2 βgeo ES clones were thawed and expanded, and the blastocysts (C57BL/6) injection and embryo transfer were done by Transgenic & Knockout-Mouse Core Facility (Indiana University School of Medicine). Based on percent coat color (agouti/black), several male chimeras were identified from blastocyst injections of both ES cell clones. At 7 weeks of age the Tgfb2 βgeo male chimeras were mated with C57BL/6 wild-type female mice, and a germ line transmission of Tgfb2 βgeo allele was successfully established. For genotyping of Tgfb2 βgeo mice, we used a Tgfb2 specific primer in the 5′ homology arm (F65) with the constant/cassette primer (R66) in the targeting cassette to detect the Tgfb2 βgeo allele. Another Tgfb2 specific primer was designed in the 3′ homology arm (R65) in order to detect the wild-type allele with a PCR fragment between the two Tgfb2 specific primers. DNA sequence of some of the Tgfb2 specific primers that were used for the genotyping includes: CACCTTTTACCTACAGATGAAGTTGC (F65, forward primer), CTTAAGACCACACTGTGAGATAATCC (R65, reverse primer). The following PCR conditions were used: denaturation: 95°C/3 min; annealing and amplification 95°C/30 sec, 60°C/30 sec, 72°C/30 sec for 35x, 72°C/3 min; 4°C hold.
For generation of mice with a Tgfb2 flox allele, Tgfb2 +/βgeo female mice were crossed to FLPeR mice. PCR primers and PCR conditions for genotyping FLPeR transgenic mice were used as recommended (Farley et al. 2000) . For initial screening of Tgfb2 flox and Tgfb2 βgeo allele, Tgfb2-5′ arm (F65), constant cassette (R66), Tgfb2-3′arm (R65) PCR primers were used. In addition, two specific sets of PCR primers which identified Tgfb2 flox but not the Tgfb2 βgeo allele were used for further confirmation. These two independent PCR genotyping reactions used gene-specific (F86) and constant cassette (R86), and gene-specific forward (F86) and reverse (R88) primers, respectively. Tgfb2 flox female mice were crossed with EIIaCre deleter mice (Holzenberger et al. 2000) . PCR genotyping for the EIIaCre transgenic pups were done as published (Doetschman et al. 2012b) . Genomic PCR on tail DNA samples (F86 and R88) were used for detecting the Cre-mediated recombination in the Tgfb2 flox/− ;EIIaCre mice. PCR genotyping for detecting Tgfb2 +/− allele was performed as described (Sanford et al. 1997) . DNA sequence of the additional primers that were used for the Tgfb2 flox or Tgfb2 cko allele genotyping included: AAGGCGCATAACGATACCAC (F86, forward primer), CCGCCTACTGCGACTATAGAGA (R86, reverse primer), ACTGATGGCGAGCTCAGACC (R88, reverse primer). The following PCR conditions were used for genotyping Tgfb2 flox or Tgfb2 cko allele: denaturation: 94°C/3 min; annealing and amplification 94°C/30 sec, 58°C/30 sec, 72°C/45 sec for 35x, 72°C/5 min; 4°C hold.
Histological, immunohistochemical and X-gal staining
Wild-type control and various groups of experimental embryos collected between E13.5 and E18.5 were processed for histological and molecular analyses as described (Azhar et al. 2011 ). Embryos were genotyped using genomic DNA extracted from tail biopsies. Hematoxylin and eosin staining was performed on 7-μm-thick serial sections of heart for routine histological examination (n=11 for E13.5-E18.5). Cardiac structure and morphology was determined by immunohistochemistry using cardiac myosin heavy chain (MF20) antibody (Developmental Studies Hybridoma Bank, Iowa). Tissue collection, processing, and β-galactosidase staining on 14 μm thick frozen (O.C.T.) tissue sections were done according to the published protocol (Komatsu et al. 2014 ). X-gal-stained tissue sections were counterstained with nuclear fast red (Vector Lab, Burlingame, CA). Images of whole embryos were captured in a stereozoom microscope (Zeiss Stemi 2000-C). All sections were visualized under brightfield optics with a Zeiss AxioLab.A1 light microscope (Carl Zeiss Microimaging, Inc.), and the morphometric measurements on the captured images were done by AxioVision Zeiss imaging software and NIH Image J (Fiji).
Real-time quantitative PCR Analysis
Real-time qPCR analysis (via intron spanning assay) was done using Universal ProbeLibrary (UPL) assay according to the manufacturer's protocols (Roche Inc, Indianapolis, IN). Expression of lacZ was detected using RT-PCR. Whole hearts from wildtype or Tgfb2 gene-trap knockout or conditional knockout fetuses at E16.5 were collected under a stereozoom microscope (Zeiss Stemi 2000-C). Total RNA was isolated by RNeasy Mini kit (Qiagen, Valencia, CA). Three different samples of wild-type and experimental fetal hearts were assessed by real-time qPCR in LightCycler 480 (Roche Inc, Indianapolis, IN). ProbeFinder Assay Design Software (Roche Inc, Indianapolis, IN) was used to select the target-specific primer sequences and the matching Mouse Universal ProbeLibrary probe. Each reaction was performed in triplicate. The relative amount of target mRNA normalized to β-actin and to the wild-type was calculated. Specific primers and probes that were used in the qPCR or RT-PCR assays included: ATCACGACGCGCTGTATC (lacZ forward primer), ACATCGGGCAAATAATATCG (lacZ reverse primer), TGGAGTTCAGACACTCAACACA (Tgfb2 exon 6-specific forward primer), AAGCTTCGGGATTTATGGTGT (Tgfb2 exon 7-specific reverse primer), TCCTCAGC (Tgfb2 exon 7-specific UPL probe #73). The UPL Reference Gene Assay for β-actin (#05046190001, Roche, Inc) was used for quantification of gene expression using dual-color real-time qPCR. The following conditions were used for lacZ PCR: denaturation-94°C/5 min; annealing and amplification-94°C/30 sec, 58°C/30 sec, 72°C/45 sec for 35x, 72°C/5 min; 12°C hold. For UPL qPCR, the following conditions were used: Pre-incubation: 95°C/4 min; Amplification: 95°C/10 sec, 60°C/30 sec, 72°C/01 sec for 45x; Cooling: 40°C/30 sec.
Statistical Analysis
All experiments were done on three or more embryos per genotype per developmental stage with similar results. Microsoft Excel was used for managing the raw data. Statistics was performed using pair-wise comparisons between the groups, utilizing analysis of variance and unpaired two-tailed t-test (SigmaPlot, Systat Software, Inc., CA). Data was reported as means ± SE of the mean. Probability values <0.05 were considered as significant. 
A-B:
Gross morphological images of wild-type (A) and Tgfb2 βgeo/βgeo (B) littermates at E17.5. Tgfb2 βgeo/βgeo fetuses appear grossly abnormal with craniofacial features and excessive or abnormal blood vessels and profuse bleeding. C: Real-time qPCR analysis of 'wild-type' Tgfb2 expression in control and Tgfb2 βgeo/βgeo fetal hearts. Total RNA from hearts of E16.5 fetuses is used to prepare the cDNA. Intron spanning Universal ProbeLibrary assay with a mouse Tgfb2 exon 7 probe (#73) along with the Tgfb2 exon 6 (forward) and Tgfb2 exon 7 (reverse) primers are used for UPL qPCR analysis. Note that there is a significant loss of wild-type Tgfb2 transcript expression in Tgfb2 βgeo/βgeo fetal hearts (*P = <0.005, n = 3 for wild-type and Tgfb2 βgeo/βgeo ). Expression levels are normalized to β-actin (via dual-color UPL real-time qPCR) and to the wild-type value. Tgfb2 flox/− ;EIIaCre − (D-E) hearts are normal. Interestingly, Tgfb2 flox/− ;EIIaCre + fetuses develop severe malformations of the cardiac outflow tract (F) (arrow, PTA; asterisks, abnormally thickened trucal valves) and inflow tract (G) (arrow, VSD; arrowhead, abnormal myocardium). These cardiac malformations are similar to the ones that are seen in the Tgfb2 βgeo/βgeo , Tgfb2 βgeo/− , Tgfb2 −/− fetuses. Scale bar =200 μm for B-G. Abbreviations: rv, right ventricle; lv, left ventricle; pt, pulmonary trunk; ao, aorta; PTA, persistent truncus arteriosus; VSD, ventricular septal defect
